Editorial: Identifying Candidates for Pegylated Interferon Add-On to Entecavir Therapy in Patients With HBeAg-positive Chronic Hepatitis B - Authors' Reply
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15155
Full Text
Open PDFAbstract
Available in full text
Date
February 11, 2019
Authors
Publisher
Wiley